Zimbabwe has rejected a significant US health deal worth $367m (272 million pounds) spanning five years because of Washington's request for sensitive biological samples.
This move was revealed after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman has since stated that the US was requesting health data for research and commercial gain while was unwilling to share the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more talks to secure a deal acceptable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development follows a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and accountability.
Based on statements, 16 African countries have so far signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Put simply, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our population should a new health crisis emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage potential pandemics.
"This framework is designed to ensure that when a nation provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns over the US deal "are not meant as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent co-operation might be designed in a way that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body stated it understood the government's concerns, but urged that talks must proceed since a large portion of the country's Aids initiatives were funded by international support.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
The situation emphasises the complex tensions between accepting much-needed international aid and protecting national sovereignty in an ever more interconnected world.